<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-12-17">December 17, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Britta</forename><surname>Siegmund</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Medicine (Gastroenterology, Infectious Diseases, Rheumatology)</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Roger</forename><forename type="middle">M</forename><surname>Feakins</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Histopathology</orgName>
								<orgName type="institution">Royal London Hospital</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Giorgos</forename><surname>Bamias</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Academic Department of Gastroenterology, Ethnikon</orgName>
								<orgName type="institution" key="instit1">Kapodistriakon University of Athens</orgName>
								<orgName type="institution" key="instit2">Laikon Hospital</orgName>
								<address>
									<settlement>Athens</settlement>
									<country key="GR">Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Juliano</forename><surname>Coelho</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution" key="instit1">ESADI Clinic and Gastroenterology Unit</orgName>
								<orgName type="institution" key="instit2">Santa Isabel Hospital</orgName>
								<address>
									<settlement>Blumenau, Santa Catarina</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Fabio</forename><surname>Vieira Teixeira</surname></persName>
							<affiliation key="aff5">
								<orgName type="institution">Colorectal Unit</orgName>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="institution">Gastrosaude Clinic</orgName>
								<address>
									<settlement>Marilia, Sao Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Department of Surgery</orgName>
								<orgName type="institution">UNESP Botucatu</orgName>
								<address>
									<settlement>Sao Paulo</settlement>
									<country key="BR">Brazil</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gerhard</forename><surname>Rogler</surname></persName>
							<affiliation key="aff8">
								<orgName type="department">Division of Gastroenterology and Hepatology</orgName>
								<orgName type="institution" key="instit1">University Hospital Zurich</orgName>
								<orgName type="institution" key="instit2">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>MD</roleName><forename type="first">Michael</forename><surname>Scharl</surname></persName>
							<email>michael.scharl@usz.ch</email>
							<affiliation key="aff8">
								<orgName type="department">Division of Gastroenterology and Hepatology</orgName>
								<orgName type="institution" key="instit1">University Hospital Zurich</orgName>
								<orgName type="institution" key="instit2">University of Zurich</orgName>
								<address>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="institution">ECCO Scientific Workshop Paper ECCO Scientific Workshop Paper</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<orgName type="department">Division of Gastroenterology and Hepatology</orgName>
								<orgName type="institution">University Hospital Zurich</orgName>
								<address>
									<addrLine>Rämistrasse 100</addrLine>
									<postCode>8091</postCode>
									<settlement>Zurich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-12-17">December 17, 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">0CCA8C028E60C3EA71423A297986C163</idno>
					<idno type="DOI">10.1093/ecco-jcc/jjv228</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:41+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Inflammatory bowel disease</term>
					<term>Crohn&apos;s disease</term>
					<term>fistula</term>
					<term>epithelial-to-mesenchymal transition</term>
					<term>mouse models</term>
					<term>cytokines</term>
					<term>genetic predisposition</term>
					<term>intestinal microbiota</term>
					<term>fibrosis</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The fifth scientific workshop of the European Crohn's and Colitis Organization (ECCO) focused on the relevance of fistulas to the disease course of patients with Crohn's disease (CD).</s><s>The objectives were to reach a better understanding of the pathophysiological mechanisms underlying the formation of CD fistulas; to identify future topics in fistula research that could provide insights into pathogenesis; to develop novel therapeutic approaches; and to review current therapeutic strategies (with clarification of existing approaches to prevention, diagnosis and treatment).</s><s>The results of the workshop are presented in two separate manuscripts.</s><s>This manuscript describes current state-of-the-art knowledge about fistula pathogenesis, including the roles of epithelial-tomesenchymal transition and cytokine matrix remodelling enzymes, and highlights the common association between fistulas and stenosis in CD.</s><s>The review also considers the possible roles that genetic predisposition and intestinal microbiota play in fistula development.</s><s>Finally, it proposes future directions and needs for fistula research that might substantially increase our understanding of this complex condition and help unravel novel therapeutic strategies and specific targets for treatment.</s><s>Overall, it aims to highlight unanswered questions in fistula research and to provide a framework for future research work.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p><s>Most patients with Crohn's disease (CD) are initially diagnosed on the basis of inflammatory pathological changes.</s><s>At diagnosis, only up to one-third of patients have evidence of a stricturing or penetrating intestinal complication. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref></s><s>However, in the setting of longstanding and chronically relapsing disease the inflammatory disease phenotype often shifts towards a stricturing and/or penetrating phenotype that is characterized by severe complications such as stenosis or fistulas.</s><s>About 70% of CD patients suffer from fistula or stenosis and associated intestinal obstruction during their lifetime and at least 60% of CD patients require surgery at least once within 20 years following their initial diagnosis. <ref type="bibr" target="#b2">3</ref></s><s>Fistulas, mainly perianal, affect between 17 and 50% of CD patients. <ref type="bibr" target="#b3">4</ref></s><s>Previous studies have demonstrated that the extent of disease at diagnosis is associated with fistula development. <ref type="bibr" target="#b3">4</ref></s><s>In contrast, patients with ileitis alone and patients undergoing laparotomy and bowel resection have a reduced risk. <ref type="bibr" target="#b4">5</ref></s><s>he driving force behind the development of CD-associated fistulas may be the phenomenon of epithelial-to-mesenchymal transition (EMT).</s><s>This is a physiological process involved in embryogenesis, organ development, wound healing and tissue remodelling, but also plays a major role in pathological processes such as tissue fibrosis and cancer progression. <ref type="bibr" target="#b6">6,</ref><ref type="bibr" target="#b7">7</ref></s><s>It is a mechanism by which epithelial cells lose their essential epithelial-defining properties, including apico-basal polarity and epithelial-specific cell contacts, and gain characteristics of mesenchymal cells, e.g.</s><s>increased motility and cell spreading. <ref type="bibr" target="#b6">6</ref></s><s>EMT is characterized by down-regulation of epitheliumspecific proteins such as E-cadherin and claudin-4 and by up-regulation of mesenchymal proteins such as vimentin. <ref type="bibr" target="#b6">6</ref></s><s>his review aims to provide a comprehensive overview of current knowledge about fistula pathogenesis, highlighting available data about the molecular pathogenesis of CD fistulas and novel factors that might also play a role.</s><s>Ideas that might contribute to the identification of future needs and directions in fistula research are explored.</s><s>These, in turn, might help the development of novel therapeutic strategies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Histopathological assessment and pathophysiology of CD-associated fistulas</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.">Definition</head><p><s>A fistula (literally a 'pipe') is a tract between two epithelium-lined surfaces.</s><s>In CD, fistulas affect up to 50% of patients <ref type="bibr" target="#b8">8,</ref><ref type="bibr" target="#b9">9</ref> and are most often perianal (54% of the total), entero-enteric (24%) or recto-vaginal (9%).</s><s>Perianal fistulas are not specific for CD.</s><s>Other causes include infection, hidradenitis suppurativa and malignancy.</s><s>Tuberculosis can mimic CD, but has a much lower prevalence than CD with regard to fistulas and perianal disease. <ref type="bibr" target="#b10">10,</ref><ref type="bibr" target="#b11">11</ref></s><s>Usually, the cause of fistula development remains unknown. <ref type="bibr" target="#b12">12</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Histology</head><p><s>Diagnosis of perianal fistulas depends on clinical assessment. <ref type="bibr" target="#b13">13</ref></s><s>There are classification systems, but these do not require histology. <ref type="bibr" target="#b13">13</ref></s><s>Biopsy, excision of associated skin tags or excision of the fistula may be done to confirm a diagnosis of CD and exclude other aetiologies. <ref type="bibr" target="#b13">13</ref></s><s>The histological features of fistulas are largely non-specific.</s><s>A fistula tract may be identifiable microscopically, lined by granulation tissue and/ or squamous epithelium and typically filled with debris, erythrocytes and acute inflammatory cells. <ref type="bibr" target="#b8">8</ref></s><s>Chronic inflammation and fibrosis are common.</s></p><p><s>Granulomas may occur in and around perianal fistulas.</s><s>In a patient with no established cause, they raise the possibility of CD.</s><s>However, a multinucleate foreign body-type giant cell reaction can occur in any type of fistula and is not specific.</s><s>Furthermore, a granulomatous reaction could reflect other aetiologies, such as mycobacterial infection, fungal infection, sarcoid or even nearby neoplasia. <ref type="bibr" target="#b12">12</ref></s><s>he granulomas of CD are typically well circumscribed and discrete with relatively few giant cells and no necrosis, but usually cannot be distinguished reliably from non-CD granulomas.</s><s>Most perianal samples from CD patients do not contain granulomas, even when the disease is established. <ref type="bibr" target="#b13">13</ref></s><s>stulas probably arise as a chronic consequence of an acute inflammatory process with infection and suppuration. <ref type="bibr" target="#b12">12</ref></s><s>For example, a deep penetrating ulcer in the rectum or anus might fill with faecal material that is forced into the underlying tissue by luminal pressure.</s><s>Anal gland or anal duct abscesses could also serve as a point of origin.</s><s>The process of tissue destruction may be maintained by luminal antigens and bacteria.</s></p><p><s>Recently, CD fistulas have been investigated in more detail.</s><s>In a study of intestinal and perianal fistulas from CD and non-CD patients, 27-31% had a lining of flattened intestinal or narrow squamous epithelium and all were surrounded by granulation tissue.</s><s>In non-epithelialized areas there was a lining of myofibroblast-like cells (termed 'transitional cells' in later studies), which could form a new basal membrane.</s><s>Fistulas in CD, but not control fistulas, had areas with disordered myofibroblasts and fragmented basal membrane, raising the possibility that mechanisms of fistula formation in CD differ from those in other settings. <ref type="bibr" target="#b8">8</ref></s><s>However, CD medications might also influence the histology. <ref type="bibr" target="#b8">8</ref></s><s>nflammatory cell populations in and around fistulas have been studied.</s><s>In one report, CD fistulas typically had central infiltration by CD45R0 + T cells, an underlying band of CD68 + macrophages and a dense CD20 + B-cell infiltrate in the outer wall.</s><s>In contrast, control fistulas typically had a dense macrophage infiltrate and sparse CD20 + B cells or CD45R T cells. <ref type="bibr" target="#b8">8</ref></s><s>In another study, CD4 + CD161 + T cells with a Th17, Th17/Th1 and Th1 phenotype accumulated in CD perianal fistulas. <ref type="bibr" target="#b14">14</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.">Epithelial-to-mesenchymal transition</head><p><s>A process that is characteristic of fistula pathogenesis in CD is EMT, which is a process of transformation from a differentiated epithelial cell to a mesenchymal-type cell. <ref type="bibr" target="#b9">9</ref></s><s>This process is associated with embryogenesis, organ development and wound repair and also with pathological fibrosis, tumour growth and metastasis. <ref type="bibr" target="#b9">9</ref></s><s>It favours the acquisition of the ability to migrate and to penetrate into adjacent layers.</s><s>In experimental models it confers invasive and metastatic characteristics and a stem cell phenotype on cancer cells. <ref type="bibr" target="#b15">15</ref></s><s>istologically, tumour budding in colorectal carcinoma [CRC] may reflect EMT and often has negative prognostic value. <ref type="bibr" target="#b16">16</ref></s><s>n EMT, cells may express epithelial markers, such as cytokeratin 8 and cytokeratin 20, together with mesenchymal markers, e.g.</s><s>vimentin and smooth muscle actin.</s><s>They have reduced expression of adhesion molecules, such as E-cadherin, and up-regulation of transcription factors, including SNAIL1 and SLUG. <ref type="bibr" target="#b9">9</ref></s><s>Known inducers of EMT include transforming growth factor (TGF)-β and tumour necrosis factor α (TNF-α).</s><s>Aspects of the process of EMT may be facilitated by specific factors; e.g.</s><s>SLUG and β6-integrin facilitate cell invasiveness.</s></p><p><s>The process of EMT may be involved in the pathogenesis of CD fistulas. <ref type="bibr" target="#b9">9</ref></s><s>In CD fistulas are lined wholly or partly by myofibroblast-like cells/ transitional cells (TCs) that express cytokeratins 8 and 20 and probably represent intestinal epithelial cells that have undergone EMT. <ref type="bibr" target="#b17">17</ref> Features in and around CD fistulas that suggest EMT onset include: lower levels of E-cadherin in TCs than in adjacent epithelial cells; SLUG expression in TCs and in underlying mesenchymal cells; overexpression and nuclear localization of SNAIL1 in TCs; high levels of TGF-β and β6-integrin in TCs and in the zone between TCs and intestinal epithelial cells; and strong expression of TNF-α and its receptor in TCs. <ref type="bibr" target="#b9">9,</ref><ref type="bibr" target="#b17">17,</ref><ref type="bibr" target="#b18">18</ref></s><s>ther molecules relevant to EMT have also been studied.</s><s>Interleukin (IL)-13 favours fibrosis, is induced by TGF-β and induces the expression of SLUG and β6-integrin in EMT models and in intestinal epithelium.</s><s>Ets1 is a transcription factor and proto-oncogene that mediates the activation of β6-integrin during EMT in an experimental model of CRC.</s><s>Dickkopf homologue 1 (DKK1) influences cell migration, is a regulator of EMT and has been associated with progression of carcinomas.</s><s>IL-13, IL-13 receptor-α, Ets1 and DKK1 are highly expressed in TCs along CD fistula tracts, favour EMT and may play a role in CD fistula pathogenesis. <ref type="bibr" target="#b9">9,</ref><ref type="bibr" target="#b19">19,</ref><ref type="bibr" target="#b20">20</ref></s><s>ucleotide oligomerization domain (NOD)2 is a receptor for the bacterial cell wall muramyl dipeptide (MDP).</s><s>NOD2 mutations have been associated with a fistulizing course in CD. <ref type="bibr" target="#b19">19</ref> Also, MDP stimulates expression of TNF-α, TGF-β, SNAIL1, IL-13 and Ets1 in intestinal epithelial cells and lamina propria fibroblasts from fistulas.</s><s>These observations support the suggestion that bacteria have a role in CD fistula formation, possibly as a result of EMT. <ref type="bibr" target="#b19">19</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4.">Matrix remodelling enzymes</head><p><s>The intercellular matrix is constantly remodelled by a number of enzymes that degrade all components of the extracellular matrix [ECM], namely the matrix metalloproteinases (MMPs).</s><s>2]<ref type="bibr" target="#b23">[23]</ref> The importance of MMPs for the development of CD is highlighted by the fact that in the murine dextran sulphate sodium-induced colitis model, targeted deletion of MMP-9 has a protective effect, <ref type="bibr" target="#b24">24,</ref><ref type="bibr" target="#b25">25</ref> while mice overexpressing MMP-9 in the intestinal epithelium develop more severe colitis when compared with wild-type animals. <ref type="bibr" target="#b26">26</ref></s><s>Furthermore, addition of MMP-3 caused extensive tissue injury in an ex vivo human foetal model of intestinal inflammation and tissue injury was effectively blocked by inhibiting MMP activity. <ref type="bibr" target="#b27">27</ref></s><s>The physiological inhibitors of MMPs are the tissue inhibitors of MMPs (TIMPs) which are also secreted by the MMP-producing cells. <ref type="bibr" target="#b21">21</ref></s><s>n CD fistulas, strong MMP-3 expression is observed independently of the stage of inflammation.</s><s>Expression of MMP-3 mRNA and protein is detected in mononuclear cells and fibroblasts. <ref type="bibr" target="#b28">28</ref></s><s>urthermore, inactive and active MMP-9 is expressed around CD fistulas and raised mRNA and protein levels are found in granulocytes and fibroblasts. <ref type="bibr" target="#b28">28,</ref><ref type="bibr" target="#b29">29</ref></s><s>The activated isoform of MMP-13 is present in the supernatant of untreated CD fistula colonic lamina propria fibroblasts (CLPFs), but is almost absent in the supernatant of non-fistula CLPFs.</s><s>Expression of MMP-13 protein is clearly detectable in mononuclear cells around CD fistulas. <ref type="bibr" target="#b9">9,</ref><ref type="bibr" target="#b29">29</ref></s><s>In contrast, expression of MMP-1 and MMP-7 is only weak around CD fistulas, MMP-10 is not detectable and MMP-2 protein is equally expressed in fistula and control tissue.</s><s>Activated MMP-2 can only be found in CD fistulas. <ref type="bibr" target="#b28">28</ref></s><s>Protein levels of TIMP-1, TIMP-2 and TIMP-3 are low around CD fistulas. <ref type="bibr" target="#b28">28</ref></s><s>These observations suggest a critical role for matrix remodelling enzymes in fistula pathogenesis.</s></p><p><s>In summary, a possible scenario for CD fistula formation is a genetically triggered, aberrant immune response to bacterial stimuli, including MDP, leading to a severe inflammatory reaction with secretion of TNF-α, IL-13 and TGF-β.</s><s>TGF-β could then induce factors associated with EMT and cell invasiveness, such as Ets1, SNAIL1 and SLUG, leading to EMT and the production of further molecules associated with cell invasiveness, such as β6-integrin.</s><s>IL-13 (induced by TGF-β) and its receptor may act in an autocrine manner to favour EMT cell penetration of deeper layers. <ref type="bibr" target="#b30">30</ref></s><s>Other regulatory proteins, such as DKK1, may also participate <ref type="bibr" target="#b9">9</ref> (Figure <ref type="figure" target="#fig_0">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5.">Fistula-associated neoplasia</head><p><s>Crohn's disease carries an increased risk of gastrointestinal cancer, with a 2-to 3-fold increase in CRC and an increase of up to 30-fold in small bowel cancer. <ref type="bibr" target="#b31">31</ref></s><s>Along with disease extent, disease duration, inflammatory activity and age of onset, the presence of persistent chronic fistulas has been cited as a risk factor for gastrointestinal malignancy. <ref type="bibr" target="#b8">8</ref></s><s>Adenocarcinoma associated with CD fistula, in comparison, is rare. <ref type="bibr" target="#b32">32</ref></s><s>4]<ref type="bibr" target="#b35">[35]</ref> The risk is associated with the duration of perianal fistulizing disease. <ref type="bibr" target="#b31">31</ref></s><s>The tumour may arise directly from the fistula, and occasionally there is dysplasia of the adjacent fistula lining. <ref type="bibr" target="#b36">36</ref></s><s>t has been suggested that adenocarcinomas associated with CD fistulas probably represent anal gland carcinoma. <ref type="bibr" target="#b8">8</ref></s><s>EMT may also be important.</s><s>In a detailed study of a fistula-associated adenocarcinoma in CD there was aberrant SLUG transcription factor expression in the transitional cells of the fistula, suggesting a role for EMT in carcinogenesis. <ref type="bibr" target="#b31">31</ref></s><s>nduce the event of epithelial-to-mesenchymal transition (EMT).</s><s>First, increased expression of TNF is initiated (3), resulting in up-regulation of TGF-β production.</s><s>This triggers a signalling cascade of molecules associated with cell invasiveness, such as β6-integrin (4).</s><s>The enhanced activity of matrix metalloproteinases (MMPs) and the up-regulation of protein expression favour the transformation of intestinal epithelial cells (IECs) towards invasive myofibroblast forms, which results in fistula formation (5).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Gut lumen</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Gut mucosa</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Submucosal tissue</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.6.">Relationship between CD-associated fistulas and hidradenitis suppurativa</head><p><s>Hidradenitis suppurativa (HS) is a chronic disease that most often affects the axilla but may be perianal.</s><s>Abscesses, sinuses, fistulas and scarring may occur.</s><s>Histologically, apocrine gland openings contain keratin and debris.</s><s>CD and HS may occur in the same patient, <ref type="bibr" target="#b37">37,</ref><ref type="bibr" target="#b38">38</ref> in which case CD usually, but not always, precedes HS. <ref type="bibr" target="#b39">39</ref> In a study of HS, 10/101 patients had discrete epithelioid granulomas away from the site of inflammation.</s><s>Of these, one had known CD and one sarcoidosis, and investigations revealed CD in a further two. <ref type="bibr" target="#b40">40</ref></s><s>he remaining seven had no cause other than HS.</s><s>Foreign body-type granulomas were found in 25%, typically related to ruptured hair follicles, sinus tracts or sweat glands <ref type="bibr" target="#b40">40</ref> .</s></p><p><s>The anatomical distribution of HS raises the possibility of an apocrine gland disorder, but follicular occlusion is now the favoured cause. <ref type="bibr" target="#b41">41,</ref><ref type="bibr" target="#b42">42</ref></s><s>Infection may play a role, though this is disputed. <ref type="bibr" target="#b43">43</ref></s><s>ccluded, dilated follicles may rupture, with extrusion of keratin and bacteria, an inflammatory response and destruction of pilosebaceous units and other adnexae.</s><s>Fragments of follicular epithelium might be the origin of sinus tracts. <ref type="bibr" target="#b43">43</ref></s><s>Hormonal imbalance may play a role, but the evidence conflicts; other contributory factors could include free radical production by neutrophils. <ref type="bibr" target="#b44">44</ref></s><s>here are a few possible similarities between the pathogenesis of HS-and CD-related fistulas.</s><s>IL-17, the caspase-1 associated cytokines IL-1β and IL-18 and the IL-23/T-helper cell type 17 pathway have been implicated, and the latter may also play a role in CD fistula formation <ref type="bibr" target="#b37">37,</ref><ref type="bibr" target="#b44">44,</ref><ref type="bibr" target="#b45">45</ref> .</s><s>In CD patients, a relatively high frequency of CD4+CD161+ T lymphocytes was detected in fistulas and in HS lesions in one report. <ref type="bibr" target="#b46">46</ref></s><s>Release of pro-inflammatory cytokines has been demonstrated in HS, with increased expression of TNF-α (a recognized contributor to the pathogenesis of CD). <ref type="bibr" target="#b44">44</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Genetic predispositions and specific immunological profiles in fistula development</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1.">Role of genetic predisposition to fistula development</head><p><s>In recent years, more than 200 genetic polymorphisms that confer increased susceptibility to (or protect from) the development of CD have been reported. <ref type="bibr" target="#b47">47,</ref><ref type="bibr" target="#b48">48</ref></s><s>Such genetic predispositions influence the likelihood that a single individual will manifest CD and may also help determine the phenotype of each case.</s><s>Accordingly, several associations between specific genotypes and fistulizing (including perianal) CD have been reported.</s><s>Variation exists between different genetic studies, as results are commonly dependent upon the characteristics of the population, including ethnic background and age.</s><s>In addition, the definition of perianal disease is not uniform: in some studies it comprises the full spectrum of anal lesions, whereas in others it is restricted to those with fistulas.</s></p><p><s>Results from the IBDchip European Project, which included 1528 Caucasian patients from eight major inflammatory bowel disease (IBD) clinics, provided useful insight into the genetic background of patients with fistulizing CD. <ref type="bibr" target="#b49">49</ref> The risk of developing internal fistulas was significantly associated with carriage of the PRDM1 (PR domain containing 1, with ZNF domain) rs7746082 variant or any NOD2 variant (increased incidence) as well as of the IL-23R rs11465804 variant (decreased incidence).</s><s>Carriage of variant alleles for ATG16L1 (autophagy-related 16-like 1) and PRDM1 were associated with earlier appearance of internal penetrating disease, whereas the variant allele for IL-23R was associated with delayed appearance.</s><s>In all, the authors reported that a 'high' genetic risk score, which was computed from the total number of risk alleles for IL-23R, LOC441108, PRDM1 and NOD2 polymorphisms, was associated with a hazard ratio of 1.43 (95% confidence interval 1.16-1.79,</s><s>p = 9.64 × 10 −04 vs 'low' score) for developing a fistulizing phenotype.</s><s>In this study, the genetic factor PUS10 (pseudouridylate synthase 10) had a significant protective effect against the development of perianal disease.</s><s>The authors of the study analysed the genetic characteristics of a West European CD cohort and found predictors for both perianal and non-perianal fistulizing disease. <ref type="bibr" target="#b50">50</ref></s><s> C allele at the CDKAL1 (CDK5 regulatory subunit associated protein 1-like 1) rs6908425 variant and the absence of NOD2 variants were independently associated with perianal fistulas.</s><s>Non-perianal fistulas were significantly affected by the presence of a T allele at rs12704036, the presence of any NOD2 variant or the IRGM (immunity-related GTPase family M member) rs4958847 G allele.</s><s>These studies demonstrate that genetic factors that affect the risk of perianal disease are clearly different from those that are associated with internal fistulas.</s></p><p><s>Several other genetic associations with fistulizing disease have been reported.</s><s>Schnitzler et al. <ref type="bibr" target="#b51">51</ref> found a significant association between the NOD2 variant rs72796353 and the development of perianal fistulas, in the absence of the three major NOD2 polymorphisms.</s><s>In Korean patients the TNFSF15 (tumour-necrosis factor superfamily of proteins member 15) rs4574921 CC genotype was significantly associated with the development of perianal fistula. <ref type="bibr" target="#b52">52</ref></s><s>inally, there are a number of reported associations between genetic polymorphisms and perianal disease without separating patients with and without fistula formation.</s><s>4]<ref type="bibr" target="#b55">[55]</ref><ref type="bibr" target="#b56">[56]</ref> Despite the differences between individual studies, it should be noted that genetic susceptibility to fistulizing disease appears to follow the general pattern of CD.</s><s>Indeed, the majority of reported associations involve genes that encode proteins that participate in the interaction between the immune system and microbial factors or regulate the integrity of the intestinal epithelial barrier.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2.">Cytokine profile in fistula patients</head><p><s>Patients with fistulizing complications constitute a large and welldefined subpopulation of CD.</s><s>Nevertheless, it remains largely unknown whether this subgroup carries a distinctive immunological phenotype that underlies the formation of fistulas, although the few studies that have addressed this question have raised the possibility that this may be the case.</s><s>An Italian group published a study of the serum concentrations of pro-inflammatory cytokines in four groups: CD patients with perianal fistulas and inactive luminal disease; patients with active intestinal CD without perianal manifestations; patients with perianal complications after restorative proctocolectomy; and healthy controls. <ref type="bibr" target="#b57">57</ref></s><s>They found that the presence of fistulas correlated with serum elevations of TNF-α and IL-6 but not of IL-12 or IL-1β.</s><s>The same group also studied the expression of cytokines in the rectal mucosa and reported that mucosal expression of IL-1β and IL-6 was higher in those with perianal CD than in those with small bowel CD and in healthy controls. <ref type="bibr" target="#b57">57</ref></s><s>Local immunostaining for TNF-α and IL-12 has also been performed in resected specimens from patients with CD and non-CD controls.</s><s>They found up-regulated expression of both proteins in patients with CD, which was related to the presence of fistulizing complications.</s><s>These findings demonstrate up-regulated expression of TNF-α in patients with fistulizing disease and are in line with the significant clinical benefit of anti-TNF-α treatment in perianal CD.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3.">Cytokine profile in fistula tissue</head><p><s>In an effort to determine the local immunological microenvironment, cytokine expression patterns were also studied in the epithelial lining of the fistula tract. <ref type="bibr" target="#b30">30</ref></s><s>Once again, TNF-α appears to be a principal component, as it is not only highly expressed by the lining epithelium but also by immune cells that surround the fistula, as well as by epithelial cells of the adjacent crypts. <ref type="bibr" target="#b18">18</ref></s><s>TNF receptor-1 is also expressed by epithelialized fistulas.</s><s>IL-13 and its α1 receptor (IL-13R1) are also abundantly expressed in the fistula lining and this is in contrast to the absence of IL-13 expression both in the healthy intestine and in non-fistulizing lesions of IBD, irrespective of the inflammatory state. <ref type="bibr" target="#b9">9</ref></s><s>Finally, TGF-β localizes in the epithelial cells that line the fistula. <ref type="bibr" target="#b17">17</ref></s><s>The presence of these cytokines in the luminal site of the fistula implies their participation in the pathogenesis of penetrating complications in CD.</s><s>These cytokines interact with each other and they all affect critical mechanisms of fistula formation such as EMT and the function of colonic lamina propria fibroblasts.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Mechanisms of fistula and fibrosis development: similarities and differences</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.1.">Pathogenesis of intestinal fibrosis</head><p><s>Fibrosis is the result of a dynamic process involving the increased synthesis of matrix components and a failure of physiological mechanisms of matrix turnover.</s><s>When a tissue or organ is injured a complex healing cascade is triggered.</s><s>This well-orchestrated process of tissue repair is of great importance for organ homeostasis.</s><s>However, an imbalance between excessive and insufficient tissue repair will impair organ function.</s><s>Formation of ulcers and fistulas on the one hand and fibrosis and stricture on the other represent two sides of the same coin. <ref type="bibr" target="#b58">58</ref></s><s>Fibrogenesis is a consequence of local chronic inflammation and is characterized by deposition of excess ECM that is produced by activated myofibroblasts.</s><s>The time taken for intestinal fibrotic lesions to progress is highly variable and may range from weeks to decades.</s><s>Deep ulcers or transmural fissures are more likely to result in fibrotic strictures.</s><s>However, it is difficult to predict which patients will develop a fibrostenosing phenotype and how rapidly this will occur.</s><s><ref type="bibr" target="#b60">[60]</ref><ref type="bibr" target="#b61">[61]</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.2.">Fibrosis in CD patients</head><p><s>The theory regarding fibrosis in CD is based on observation of an extreme healing response to injury.</s><s>9]<ref type="bibr" target="#b60">[60]</ref> These cells are characterized by an enhanced ability to trigger ECM synthesis.</s><s>However, following acute injury the normal intestinal architecture is restored, and some mechanisms prevent the accumulation of ECM while fibrogenic cells are eliminated.</s><s>In contrast, the mechanisms serving to degrade ECM are not operative at appropriate levels during fibrosis, and fibrogenic cells are not only maintained but increase in number.</s><s><ref type="bibr" target="#b61">[61]</ref> Population-based studies may help us to understand the natural history of fibrosis in IBD. <ref type="bibr" target="#b62">62,</ref><ref type="bibr" target="#b63">63</ref></s><s>In a large paediatric CD population-based registry, a French group reported that more than 70% of patients had an inflammatory phenotype at diagnosis.</s><s>Eight years after diagnosis, 40% of the children developed a stricturing phenotype. <ref type="bibr" target="#b64">64</ref></s><s>In adults, 79% of CD patients had an inflammatory phenotype at diagnosis.</s><s>Ten years later, 43% had developed intestinal fibrosis. <ref type="bibr" target="#b65">65</ref></s><s>Also, there is evidence that intestinal inflammation is the major driving force for fibrosis in CD. <ref type="bibr" target="#b64">64,</ref><ref type="bibr" target="#b65">65</ref> Fibrosis in ulcerative colitis (UC) patients is not as severe as in CD, but it can be observed.</s><s>De Bruyn and colleagues <ref type="bibr" target="#b66">66</ref> showed no significant difference in collagen deposition, presence of ECM or myofibroblast numbers between acute and longstanding UC.</s><s>It seems that acute UC inflammation leads to activation of ECM-degrading enzymes, such as MMP and elastase.</s><s>Moreover, this activation process improves collagenase activity and contributes to degradation of ECM components, including fibronectin and collagen.</s><s><ref type="bibr" target="#b68">[68]</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.3.">Fibrosis in the liver and the lung</head><p><s>The fibrogenesis process is a common pathway in different conditions.</s><s>Beyond the intestine, fibrosis may develop in e.g.</s><s>liver and lung, though with different genesis and evolution.</s><s>Liver fibrosis is a common long-term pathological consequence of different causes, such as viral hepatitis, including chronic hepatitis B and chronic hepatitis C. Due to continuous replacement of normal liver tissue with ECM, liver fibrosis results in progressive distortion of the normal hepatic architecture.</s><s>These changes can evolve into cirrhosis. <ref type="bibr" target="#b69">69</ref></s><s>The activation of hepatic stellate cells by inflammation stimulates their differentiation into myofibroblasts, including the capacity to induce proliferation and fibrogenesis.</s><s>Similar to what occurs in intestinal fibrosis, imbalance between the degradation of stimulating factors and ECM results in an abundance of this matrix and consequently in the development of hepatic fibrosis. <ref type="bibr" target="#b69">69,</ref><ref type="bibr" target="#b70">70</ref></s><s>In the lung, the activation and proliferation of fibroblasts by local or systemic inflammatory mechanisms have been associated with changes in the alveolar epithelium resulting in the accumulation of ECM and remodelling of lung architecture, characteristic features of fibrotic lung disease. <ref type="bibr" target="#b71">71</ref></s><s>n important point in the intestinal fibrogenesis process is the direct activation of myofibroblasts by pro-inflammatory mediators and subsequent ECM production. <ref type="bibr" target="#b58">58</ref></s><s>On the other hand, in liver diseases, hepatic stellate cells play a key role in disease genesis by their extraordinary ability to differentiate into myofibroblasts. <ref type="bibr" target="#b69">69</ref></s><s>ifferently, in the lung local as well as systemic fibroblasts are being recruited and induce early activation of epithelial mesenchymal cells, hence resulting in fibrosis. <ref type="bibr" target="#b71">71</ref></s><s>Briefly, activation and differentiation of fibroblast cells by different routes associated with the imbalance between matrix factors and cell stabilizers seem to be central to the pathophysiology of fibrosis in different organs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.4.">Fistula versus fibrosis development</head><p><s>In contrast to fibrosis and the related strictures, a fistula is defined as a chronic tract between two epithelium-lined surfaces. <ref type="bibr" target="#b68">68</ref></s><s>When perianal disease is the first manifestation of CD, severe disease is likely and there may be rapid progress from inflammatory manifestations to stricturing or penetrating complications.</s></p><p><s>Interestingly, there seem to be pathophysiological mechanisms that contribute to the development of both fibrosis and fistulas in IBD patients.</s><s>EMT, which seems to be the driving force for fistula development, also plays a key role in the development of fibrosis in CD. <ref type="bibr" target="#b7">7,</ref><ref type="bibr" target="#b72">72</ref> Furthermore, aberrant activation of matrix remodelling enzymes such as MMP-3 and MMP-9, as well as of cytokines and growth factors such as TGF-β and IL-13, are important for fibrosis as well as fistula development. <ref type="bibr" target="#b7">7,</ref><ref type="bibr" target="#b9">9,</ref><ref type="bibr" target="#b17">17,</ref><ref type="bibr" target="#b28">28</ref></s><s>However, although those factors contribute to the development of both fibrosis and fistulas, it is not clear why stenosis occurs in some patients and fistulas in others.</s><s>Notably, fistulas are often surrounded by fibrotic tissue, suggesting that these disease manifestations can exist together and might originate from similar events.</s><s>However, the additional mechanisms that need to occur in CD patients to favour fistula development over fibrosis require further investigation.</s><s>In addition, it is important to understand why fibrosis and fistulas are a common complication in CD patients but not in UC.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Role of microbiota in fistula and fibrosis development: similarities and differences</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.1.">Intestinal microbiota in IBD</head><p><s>The role of microbiota in IBD has gained increasing attention in recent years.</s><s>Previously, there was clear evidence that the intestinal microbiota play a crucial role in mediating disease, mainly in the form of absent inflammation in germfree mice in models of experimental colitis. <ref type="bibr" target="#b73">73</ref></s><s>Furthermore, early clinical studies indicated that faecal stream diversion can ameliorate human IBD. <ref type="bibr" target="#b74">74</ref></s><s>In recent years, it has been demonstrated that microbial diversity increases in 'intestinal' health but decreases in inflammation. <ref type="bibr" target="#b75">75,</ref><ref type="bibr" target="#b76">76</ref></s><s>There is evidence from controlled clinical studies that the transplantation of microbiota might become a therapeutic strategy to ameliorate inflammation, but many questions need to be answered before this approach is considered in practice. <ref type="bibr" target="#b75">75,</ref><ref type="bibr" target="#b76">76</ref></s><s>While the impact of microbiota on inflammation has been studied, their role in fistula and fibrosis development has scarcely been addressed.</s><s>Here we aim to summarize the available data for IBD as well as for other diseases.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.2.">Intestinal microbiota in fibrotic disease</head><p><s>When different organs are compared we find that there are substantially more data on fibrosis than on fistula development.</s><s>Ligands to toll-like receptor (TLR) 4 or TLR2, predominantly Gram-negative and -positive bacteria, activate the NFκB (nuclear factor κ-lightchain-enhancer of activated B cells) pathway leading to the secretion of cytokines and chemokines by intestinal mesenchymal cells, thus contributing to the production of pro-fibrotic factors. <ref type="bibr" target="#b77">77</ref></s><s>In addition, experimental models, including SAMP1/YitFc and IL-10-deficient mice as well as benzene sulphonic acid (TNBS)-and peptidoglycanpolysaccharide (PG-PS)-induced colitis, indicate that not only are the intestinal microbiota required for intestinal inflammation but that they also perpetuate gut fibrosis. <ref type="bibr" target="#b73">73</ref></s><s>Activated mesenchymal cells can be considered as major driving factors for intestinal fibrosis, since these cells produce several collagen types, including types I, III and V, <ref type="bibr" target="#b59">[59]</ref><ref type="bibr" target="#b60">[60]</ref><ref type="bibr" target="#b61">[61]</ref> as well as ECM products such as fibronectin and tenascin C. <ref type="bibr" target="#b78">78,</ref><ref type="bibr" target="#b79">79</ref> The deposition and formation of networks ultimately contribute to tissue stiffness, which subsequently activates further mesenchymal cells in a positive feedback loop, hence increasing fibrosis development. <ref type="bibr" target="#b80">80</ref></s><s>TGF-β1 can be considered as a central mediator in this context. <ref type="bibr" target="#b81">81</ref></s><s>The majority of these core mechanisms are shared between the human intestine and other organs, such as the liver, lung, kidney and skin. <ref type="bibr" target="#b82">82</ref></s><s>However, there are also organ-specific differences.</s><s>4]<ref type="bibr" target="#b85">[85]</ref> Mechanistically, this can be explained by a TNFα-mediated activation of mesenchymal cells resulting in increased TIMP-1 expression and parallel inhibition of MMP-2 activity and collagen degradation. <ref type="bibr" target="#b86">86</ref></s><s>Strikingly, human intestinal myofibroblasts isolated from CD patients exhibit increased production of TIMP-1 and decreased collagen production upon exposure to infliximab. <ref type="bibr" target="#b87">87</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.3.">Intestinal microbiota in fistulizing disease</head><p><s>Having outlined the impact of microbiota on fibrosis, the question arises of their potential role in fistula formation.</s><s>9]<ref type="bibr" target="#b90">[90]</ref> Furthermore, only a limited number of bacteria were found.</s><s>From this the authors concluded that permanent infection is not a major contributing factor to the persistence of fistulas.</s><s>From today's point of view these conclusions are questionable since conventional culture techniques were applied.</s><s>Hence these analyses require repetition and the application of modern molecular techniques that are independent of the viability of the bacteria. <ref type="bibr" target="#b91">91,</ref><ref type="bibr" target="#b92">92</ref></s><s>A recent study addressed this deficit and assessed the distal part of surgically removed fistula tracts, analysing fistula content by culture and 16S rRNA gene sequencing.</s><s>In addition, the presence of the pro-inflammatory peptidoglycan was investigated using immunohistochemistry. <ref type="bibr" target="#b93">93</ref> The bacterial species identified were bowel-and/or skin-derived and no mycobacteria were identified.</s><s>Sequencing of 16S rRNA failed to detect bacteria except in one sample, probably due to a low number of organisms.</s><s>However, peptidoglycans were detected in 90% of patients.</s><s>The authors concluded that peptidoglycan contributes to the ongoing inflammation in perianal fistulas.</s><s>Therefore, additional studies are required, applying novel sequencing strategies that will allow the analysis of even small sample sizes.</s><s>Additionally, Karban and colleagues <ref type="bibr" target="#b94">94</ref> studied the microbiology of the fistula tract of CD patients.</s><s>They aspirated and analysed pus from the tract using standard culture techniques.</s><s>The authors found a predominance of Gram-positive (staphylococci and streptococci) over Gram-negative bacteria, in contrast to perianal fistulas of cryptoglandular origin (not CD-associated fistulas), which preferentially have bacteria of gastrointestinal origin.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.">Defining future directions in fistula research</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.1.">Lack of mouse models in fistula research</head><p><s>To date, defining the pathophysiology and pathogenesis of CD-associated fistulas has been a relatively neglected area of research.</s><s>Our current knowledge about the development of fistulas derives from descriptive immunohistochemical data and from in vitro and ex vivo cell model experiments.</s><s>Additional clinical observations are certainly helpful, but are not sufficient to unravel the mechanistic and/or molecular processes that result in fistulas in CD patients.</s></p><p><s>To obtain a better understanding of the complex aetiology of fistulas, the efforts of a larger number of research groups may be needed.</s><s>A major drawback of fistula research is the fact that no reliable and reproducible animal model -the mouse in particularof intestinal fistulas exists.</s><s>Current colitis models, such as the dextran sodium sulphate colitis model, the TNBS (2,4,6-trinitrobenzenesulphonic acid) colitis model, the T-cell-transfer colitis model and the IL-10 knockout colitis model, do not develop fistulas.</s><s>This prevents investigators from obtaining sufficient in vivo data for unravelling fistula pathogenesis, and in turn developing novel fistula therapy strategies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.2.">SAMP1/Yit mice</head><p><s>So far, only a few mouse models that might develop intestinal fistulas have been described.</s><s>The first model is the SAMP1/Yit mouse.</s><s>After more than 20 generations of brother-sister mating the incidence of perianal disease within the described colony was 4.8% and involved predominantly young female mice at an age between 3.5 and 24 weeks.</s><s>The male:female ratio was 1:6.7.</s><s>However, no phenotypic differences in perianal lesions were observed between the sexes.</s><s>In this model, inflammation is characterized by mucosal ulceration of the anal canal, with fissures that occasionally extend 1 or 2 cm from the anal orifice.</s><s>Increased submucosal chronic inflammatory infiltrates (lymphocytes, plasma cells and macrophages) in the anal and rectal canals as well as accumulation of neutrophils in the perianal soft tissue, which occasionally coalesce to form perirectal abscesses, can be observed in the affected animals.</s><s>Anocutaneous fistulas, documented by insertion of a probe and by histological sections, comprise granulation tissue-lined tracts connecting the anus to the lateral skin.</s><s>Multiple fistulas are not observed and the progression of perianal inflammation to fistulas is observed in 40% of mice, in which superficial perianal ulceration appears to develop into fistulous tracts. <ref type="bibr" target="#b95">95</ref></s><s>However, this demonstrates that this model can be used neither on a routine basis for studying fistula development nor for testing novel fistula therapies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.3.">Atg7/Xbp1ΔIEC mice</head><p><s>A further novel model is the Atg7/Xbp1 ΔIEC mouse, which feature loss of Atg7 and Xbp1 in intestinal epithelial cells.</s><s>More than 70% of these animals develop discontinuous submucosal or transmural inflammation, characterized by acute and chronic inflammation extending in an abrupt knife-like fashion to the muscularis propria and serosa, closely resembling the fissuring ulcers and fistula tracts observed in human CD.</s><s>Interestingly, all animals exhibited submucosal or transmural disease in this study after 18 weeks. <ref type="bibr" target="#b96">96</ref></s><s>However, this model needs further validation with respect to fistula development before it can be used on a routine basis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.4.">Other mouse models</head><p><s>Several surgically induced fistula models have been developed.</s><s>Unfortunately, these models, which also included rats and dogs, were mostly not feasible because of severe side effects, infections and perioperative mortality.</s><s>However, one of the mouse models seemed to be usable.</s><s>In these animals, a caecostoma was created surgically.</s><s>Although the operation was easy to perform, and although neither spontaneous closure of the fistula nor premature death occurred, this mouse model of an enterocutaneous fistula was not subsequently followed up. <ref type="bibr" target="#b97">97</ref></s><s>]<ref type="bibr" target="#b100">[100]</ref> Given the importance of in vivo models for the investigation of pathogenetic features and the mechanisms underlying certain diseases, it is obvious that the development of a reliable and reproducible in vivo fistula model would be of great value.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.5.">Morphological characterization of fistulas</head><p><s>In the absence of a reliable mouse or animal model, in vitro and ex vivo experiments gain even more importance.</s><s>For a better understanding of the pathogenesis of CD fistulas, it is critical to define the histological characteristics of CD fistulas and, in particular, the ways in which they differ from non-CD fistulas.</s><s>Also, more knowledge about possible differences between actively inflamed CD fistulas, CD fistulas after treatment and chronically persisting CD fistulas without signs of acute inflammation would be useful.</s><s>In addition, more details about the specific cell types and characteristics of the cells along, as well as surrounding, the fistula tracts are required.</s><s>Though we have studied certain properties of colonic lamina propria fibroblasts derived from CD fistulas, there is relatively little knowledge about functional properties of intestinal epithelial cells, transitional cells, immune cells, etc. in and around fistulas.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.6.">MicroRNAs</head><p><s>On a molecular level, recent data suggest that microRNAs (miRs) play a pivotal role in IBD pathogenesis.</s><s>MicroRNAs are small non-coding RNAs with a length of 18-23 nucleotides that act as post-transcriptional regulators of gene expression. <ref type="bibr" target="#b101">101</ref></s><s>Schaefer and colleagues <ref type="bibr" target="#b102">102</ref> have demonstrated that microRNA signatures can distinguish CD from UC and have suggested that microRNAs could contribute to CD pathogenesis.</s><s>Furthermore, microRNAs seem able to classify different disease behaviour phenotypes in CD and might even have prognostic impact.</s><s>Of particular interest, the expression levels of miR-215 in index biopsies of CD patients might predict the likelihood of progression to penetrating/fistulizing CD. <ref type="bibr" target="#b103">103</ref> MicroRNAs represent an emerging field in IBD research, and accordingly it might be interesting to evaluate their role in fistula pathogenesis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6.7.">Intestinal microbiota</head><p><s>As described above, the intestinal microbiota might contribute to fistula pathogenesis in IBD patients.</s><s>To date, knowledge about microbiota composition within fistula tracts and about possible differences between fistulized and non-fistulized areas in individual patients, as well as differences between patients with fistulas and those without, is almost completely lacking.</s><s>Therefore, one of the major goals for future fistula research should be to investigate the composition of such microbiota, their effects on intestinal cells, and their relevance to pathogenesis.</s><s>This might allow the identification of microbiotabased strategies for fistula treatment.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="7.">Conclusion</head><p><s>In summary, fistulas represent a severe and still unresolved problem in the management of CD patients.</s><s>Current knowledge about fistula pathophysiology is still poor.</s><s>It appears that CD fistulas develop as a result of EMT, probably in areas with chronic ongoing inflammation.</s><s>Furthermore, fistula-associated cells need to acquire markers associated with cell invasiveness that then contribute to the development of invasive fistula tracts.</s><s>Emerging evidence suggests that a specific immune cell and cytokine profile can be detected around CD fistulas and that genetic factors as well as intestinal microbiota might also be involved A drawback in unravelling fistula pathogenesis and the development of novel fistula therapies is the absence of a suitable animal model.</s><s>Therefore, future research should be directed towards the generation of such an in vivo model to allow fistula research in reallife circumstances.</s><s>Additionally, better characterization of fistulas is needed, with more focus on the effects of microRNAs and intestinal microbiota.</s><s>The aim would be the identification of the driving forces for fistula development, fistula progression and, perhaps, fistula closure.</s><s>This might in turn facilitate the development of new and more effective therapeutic strategies for the treatment of patients suffering from CD fistula.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.Pathogenesis of Crohn's disease-associated fistulae.</s><s>Due to an epithelial barrier defect, several pathogen-associated molecular patterns (PAMPs), such as muramyl dipeptide (MDP), are able to enter the gut mucosa.</s><s>Both the process of wound repair (1) and the inflammatory response caused by PAMPs (2) induce the event of epithelial-to-mesenchymal transition (EMT).</s><s>First, increased expression of TNF is initiated (3), resulting in up-regulation of TGF-β production.</s><s>This triggers a signalling cascade of molecules associated with cell invasiveness, such as β6-integrin (4).</s><s>The enhanced activity of matrix metalloproteinases (MMPs) and the up-regulation of protein expression favour the transformation of intestinal epithelial cells (IECs) towards invasive myofibroblast forms, which results in fistula formation(5).</s></p></div></figDesc></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>No study sponsors had any involvement in study design, data collection, interpretation or writing of the manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of Interest</head><p><s>BS has served as consultant for Abbvie, Janssen, Hospira, MSD, Mundipharma and Takeda and has received speaker fees from Abbvie, Falk, Ferring, Hospira, MSD and Takeda.</s><s>RMF has nothing to disclose.</s><s>GB has received lecture honoraria from Takeda, MSD and Abbvie.</s><s>JCL has provided consultancy and received payment for lectures from Abbvie, Janssen and Takeda.</s><s>FVT has provided consultancy and received payment for lectures from Abbvie, Janssen, Ferring, Nestlé and Hospira.</s><s>GR has provided consultancy for Abbot, Abbvie, Augurix, Boehringer, Calypso, FALK, Ferring, Fisher, Genentech, Essex/MSD, Novartis, Pfizer, Phadia, Roche, UCB, Takeda, Tillots, Vifor, Vital Solutions and Zeller; received speaker's honoraria from Astra Zeneca, Abbott, Abbvie, FALK, MSD, Phadia, Tillots, UCB and Vifor; and received educational grants and research grants from Abbot, Abbvie, Ardeypharm, Augurix, Calypso, Essex/MSD, FALK, Flamentera, Novartis, Roche, Takeda, Tillots, UCB and Zeller.</s><s>MS has received speaker's honoraria from FALK.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Contributions</head><p><s>This article is a result of a joint scientific workshop activity.</s><s>Hence, all authors participated sufficiently, intellectually or practically, in the work to take public responsibility for the content of the article, including the conception, design, data interpretation and writing of the article.</s><s>The final version of the article was approved by all authors.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The natural history of adult Crohn&apos;s disease in population-based cohorts</title>
		<author>
			<persName><forename type="first">L</forename><surname>Peyrin-Biroulet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Loftus</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Colombel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="289" to="297" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Long-term evolution of disease behavior of Crohn&apos;s disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Cosnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cattan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Blain</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Inflamm Bowel Dis</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="244" to="250" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Hospitalisations and surgery in Crohn&apos;s disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Bernstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Loftus</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Ng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="622" to="629" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The natural history of fistulizing Crohn&apos;s disease in Olmsted County</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">V</forename><surname>Loftus</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Tremaine</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="875" to="880" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">W</forename><surname>Kruis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Scheuchenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Scheurlen</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>Risk factors for the development of fistulas in Crohn disease</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Z Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="313" to="316" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The basics of epithelial-mesenchymal transition</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kalluri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Weinberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="1420" to="1428" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Epithelial-mesenchymal transition and its implications for fibrosis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kalluri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">G</forename><surname>Neilson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="1776" to="1784" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Morphological characterisation of Crohn&apos;s disease fistulae</title>
		<author>
			<persName><forename type="first">F</forename><surname>Bataille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Klebl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rummele</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="1314" to="1321" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Interleukin-13 and transforming growth factor beta synergise in the pathogenesis of human intestinal fistulae</title>
		<author>
			<persName><forename type="first">M</forename><surname>Scharl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Frei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pesch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="63" to="72" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Clinical, endoscopic and histological differentiations between Crohn&apos;s disease and intestinal tuberculosis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Digestion</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="202" to="209" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Clinical, endoscopic, and histological differentiations between Crohn&apos;s disease and intestinal tuberculosis</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Makharia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Srivastava</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Das</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="642" to="651" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Inflammatory and neoplastic disorders of the anal canal</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Plesec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Owens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas</title>
				<editor>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Odze</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Goldblum</surname></persName>
		</editor>
		<imprint>
			<publisher>Elsevier</publisher>
			<biblScope unit="volume">2015</biblScope>
			<biblScope unit="page" from="887" to="920" />
		</imprint>
	</monogr>
	<note>3rd edn</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Diagnosis and treatment of perianal Crohn disease: NASPGHAN clinical report and consensus statement</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>De Zoeten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Pasternak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mattei</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Gastroenterol Nutr</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="401" to="412" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">CD4+CD161+ T lymphocytes infiltrate Crohn&apos;s disease-associated perianal fistulas and are reduced by anti-TNF-alpha local therapy</title>
		<author>
			<persName><forename type="first">L</forename><surname>Maggi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Capone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Giudici</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int Arch Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="page" from="81" to="86" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">B7H1 expression and epithelial-to-mesenchymal transition phenotypes on colorectal cancer stem-like cells</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Mou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">e0135528</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Tumor budding in colorectal carcinoma: time to take notice</title>
		<author>
			<persName><forename type="first">B</forename><surname>Mitrovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Schaeffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Riddell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mod Pathol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1315" to="1325" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn&apos;s disease</title>
		<author>
			<persName><forename type="first">F</forename><surname>Bataille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rohrmeier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bates</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Inflamm Bowel Dis</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1514" to="1527" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Potential role for SNAIL family transcription factors in the etiology of Crohn&apos;s disease-associated fistulae</title>
		<author>
			<persName><forename type="first">M</forename><surname>Scharl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Furst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Inflamm Bowel Dis</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1907" to="1916" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">A role for tumor necrosis factor and bacterial antigens in the pathogenesis of Crohn&apos;s disease-associated fistulae</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Frei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pesch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Inflamm Bowel Dis</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="2878" to="2887" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The role for dickkopf-homolog-1 in the pathogenesis of Crohn&apos;s disease-associated fistulae</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Frei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hemsley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pesch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">e78882</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Matrix metalloproteinases: biologic activity and clinical implications</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Nelson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fingleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Rothenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1135" to="1149" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Expression of matrix metalloproteases in inflammatory bowel disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Baugh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Hollander</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">859</biblScope>
			<biblScope unit="page" from="249" to="253" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease</title>
		<author>
			<persName><forename type="first">B</forename><surname>Von Lampe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Barthel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Coupland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="63" to="73" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Castaneda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Walia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vijay-Kumar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="1991" to="2008" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice</title>
		<author>
			<persName><forename type="first">A</forename><surname>Santana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Medina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Paz-Cabrera</forename><surname>Mc</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="6464" to="6472" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Constitutive expression of MMP9 in intestinal epithelium worsens murine acute colitis and is associated with increased levels of proinflammatory cytokine Kc</title>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Walter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Gastrointest Liver Physiol</title>
		<imprint>
			<biblScope unit="volume">304</biblScope>
			<biblScope unit="page" from="G793" to="803" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">A major role for matrix metalloproteinases in T cell injury in the gut</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Pender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Tickle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Docherty</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">158</biblScope>
			<biblScope unit="page" from="1582" to="1590" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn&apos;s disease</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kirkegaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bruun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="701" to="709" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Expression of interleukins 22 and 33, matrix metalloproteinases 9 and 13, mast cell markers and hypoxia-inducible factor 1α in Crohn&apos;s disease associated fistulae</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Frei</surname></persName>
		</author>
		<author>
			<persName><surname>Ls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Jehle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fried</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rogler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Scharl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology DDW</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="441" to="442" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Pathophysiology of fistula formation in Crohn&apos;s disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Scharl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rogler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World J Gastrointest Pathophysiol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="205" to="212" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Epithelial-to-mesenchymal transition in a fistula-associated anal adenocarcinoma in a patient with long-standing Crohn&apos;s disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Scharl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Frei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Frei</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="114" to="118" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Fistula-associated anal adenocarcinoma in Crohn&apos;s disease</title>
		<author>
			<persName><forename type="first">I</forename><surname>Iesalnieks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>Gaertner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Glass</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Inflamm Bowel Dis</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="1643" to="1648" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Anal adenocarcinoma complicating chronic Crohn&apos;s disease</title>
		<author>
			<persName><forename type="first">I</forename><surname>Papaconstantinou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Mantzos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kondi-Pafiti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Surg Case Rep</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="201" to="203" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Perianal mucinous adenocarcinoma arising from a chronic fistula-in-ano</title>
		<author>
			<persName><forename type="first">L</forename><surname>Deruyter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Venken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maetens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Chir Belg</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="page" from="410" to="413" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Mucinous carcinoma in Crohn&apos;s disease originating in a fistulous tract</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Perry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Webber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World J Gastrointest Oncol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="307" to="310" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Adenocarcinoma arising from chronic perianal Crohn&apos;s disease: case report and review of the literature</title>
		<author>
			<persName><forename type="first">R</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hicks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">I</forename><surname>Tomljanovich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am Surg</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="59" to="61" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">The prevalence of hidradenitis suppurativa in 1093 patients with inflammatory bowel disease</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Van Der Zee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Winter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Van Der Woude</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Dermatol</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="page" from="673" to="675" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Features of patients with Crohn&apos;s disease and hidradenitis suppurativa</title>
		<author>
			<persName><forename type="first">N</forename><surname>Kamal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Buche</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="71" to="79" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Hidradenitis suppurativa and Crohn&apos;s disease: two cases that support an association</title>
		<author>
			<persName><forename type="first">S</forename><surname>Yazdanyar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Jemec</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Dermatovenerol Alp Pannonica Adriat</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="23" to="25" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Granulomatous hidradenitis suppurativa and cutaneous Crohn&apos;s disease</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Attanoos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Appleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Hughes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Histopathology</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="111" to="115" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Hidradenitis suppurativa</title>
		<author>
			<persName><forename type="first">J</forename><surname>Revuz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Eur Acad Dermatol Venereol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="985" to="998" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Hidradenitis suppurativa: a comprehensive review</title>
		<author>
			<persName><forename type="first">A</forename><surname>Alikhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Lynch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Eisen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Acad Dermatol</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="562" to="563" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Hidradenitis suppurativa: pathogenesis and management</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Slade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Powell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Mortimer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Plast Surg</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="451" to="461" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Hidradenitis suppurativa: current views on epidemiology, pathogenesis, and pathophysiology</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Micheletti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Cutan Med Surg</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="S48" to="50" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Dysregulated cytokine expression in lesional and non-lesional skin in hidradenitis suppurativa</title>
		<author>
			<persName><forename type="first">G</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mc</forename><surname>Garry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Dermatol</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="page" from="1431" to="1439" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Perianal Crohn&apos;s disease and hidradenitis suppurativa: a possible common immunological scenario</title>
		<author>
			<persName><forename type="first">F</forename><surname>Giudici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Maggi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Santi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Mol Allergy</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">12</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease</title>
		<author>
			<persName><forename type="first">L</forename><surname>Jostins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ripke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Weersma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">491</biblScope>
			<biblScope unit="page" from="119" to="124" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Genetic sharing and heritability of paediatric age of onset autoimmune diseases</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">R</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">8442</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Genetic factors conferring an increased susceptibility to develop Crohn&apos;s disease also influence disease phenotype: results from the IBDchip European Project</title>
		<author>
			<persName><forename type="first">I</forename><surname>Cleynen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Gonzalez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Figueroa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="1556" to="1565" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Genetic risk profiling and prediction of disease course in Crohn&apos;s disease patients</title>
		<author>
			<persName><forename type="first">L</forename><surname>Henckaerts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Van Steen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Verstreken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="972" to="980" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">The NOD2 single nucleotide polymorphism rs72796353 (IVS4+10 A&gt;C) is a predictor for perianal fistulas in patients with Crohn&apos;s disease in the absence of other NOD2 mutations</title>
		<author>
			<persName><forename type="first">F</forename><surname>Schnitzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Friedrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wolf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">e0116044</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">TNFSF15 is an independent predictor for the development of Crohn&apos;s disease-related complications in Koreans</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Song</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Crohns Colitis</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="1315" to="1326" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Association of organic cation transporter risk haplotype with perianal penetrating Crohn&apos;s disease but not with susceptibility to IBD</title>
		<author>
			<persName><forename type="first">S</forename><surname>Vermeire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pierik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hlavaty</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="1845" to="1853" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Polymorphism of the IRGM gene might predispose to fistulizing behavior in Crohn&apos;s disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Latiano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Palmieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cucchiara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="110" to="116" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Clinical and genetic risk factors for perianal Crohn&apos;s disease in a population-based cohort</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">W</forename><surname>Eglinton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pearson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="589" to="596" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Genetic susceptibility has a more important role in pediatric-onset Crohn&apos;s disease than in adult-onset Crohn&apos;s disease</title>
		<author>
			<persName><forename type="first">L</forename><surname>De Ridder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Weersma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dijkstra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Inflamm Bowel Dis</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1083" to="1092" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Cytokine network in chronic perianal Crohn&apos;s disease and indeterminate colitis after colectomy</title>
		<author>
			<persName><forename type="first">C</forename><surname>Ruffolo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Scarpa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Faggian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Gastrointest Surg</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="16" to="21" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Wound healing and fibrosis in intestinal disease</title>
		<author>
			<persName><forename type="first">F</forename><surname>Rieder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Brenmoehl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Leeb</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="130" to="139" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Themes in fibrosis and gastrointestinal inflammation</title>
		<author>
			<persName><forename type="first">C</forename><surname>Fiocchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Lund</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Gastrointest Liver Physiol</title>
		<imprint>
			<biblScope unit="volume">300</biblScope>
			<biblScope unit="page" from="G677" to="G683" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Monitoring fibrogenic progression in the liver</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Gressner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Chim Acta</title>
		<imprint>
			<biblScope unit="volume">433</biblScope>
			<biblScope unit="page" from="111" to="122" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">IGF-I and procollagen alpha1(I) are coexpressed in a subset of mesenchymal cells in active Crohn&apos;s disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Pucilowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Mcnaughton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Mohapatra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Gastrointest Liver Physiol</title>
		<imprint>
			<biblScope unit="volume">279</biblScope>
			<biblScope unit="page" from="G1307" to="1322" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Clinical course in Crohn&apos;s disease: results of a Norwegian population-based ten-year follow-up study</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Solberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Vatn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Hoie</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Gastroenterol Hepatol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="1430" to="1438" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">C</forename><surname>Solberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lygren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jahnsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="431" to="440" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Natural history of pediatric Crohn&apos;s disease: a population-based cohort study</title>
		<author>
			<persName><forename type="first">G</forename><surname>Vernier-Massouille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Balde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Salleron</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="1106" to="1113" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Behaviour of Crohn&apos;s disease according to the Vienna classification: changing pattern over the course of the disease</title>
		<author>
			<persName><forename type="first">E</forename><surname>Louis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Collard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Oger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="777" to="782" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Development of fibrosis in acute and longstanding ulcerative colitis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>De Bruyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Meijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Wildenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Crohns Colitis</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="966" to="972" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Current misunderstandings in the management of ulcerative colitis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ochsenkuhn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Haens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1294" to="1299" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Ulcerative colitis</title>
		<author>
			<persName><forename type="first">I</forename><surname>Ordas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Eckmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Talamini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="page" from="1606" to="1619" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Clinical advances in fibrosis progression of chronic hepatitis B and C</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Lu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Transl Hepatol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="222" to="227" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Molecular pathogenesis of liver fibrosis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Brenner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trans Am Clin Climatol Assoc</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="361" to="368" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Molecular and cellular mechanisms of pulmonary fibrosis</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Todd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">G</forename><surname>Luzina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Atamas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Fibrogenesis Tissue Repair</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">11</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Hallmarks of epithelial to mesenchymal transition are detectable in Crohn&apos;s disease associated intestinal fibrosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Scharl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Transl Med</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">1</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease</title>
		<author>
			<persName><forename type="first">F</forename><surname>Rieder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Gastrointest Liver Physiol</title>
		<imprint>
			<biblScope unit="volume">303</biblScope>
			<biblScope unit="page" from="G786" to="801" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Effect of faecal stream diversion on recurrence of Crohn&apos;s disease in the neoterminal ileum</title>
		<author>
			<persName><forename type="first">P</forename><surname>Rutgeerts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Goboes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Peeters</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">338</biblScope>
			<biblScope unit="page" from="771" to="774" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Moayyedi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Surette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="102" to="109" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Fecal microbiota transplantation as novel therapy in gastroenterology: a systematic review</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Rossen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Macdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>De Vries</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">World J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="5359" to="5371" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">EMT: when epithelial cells decide to become mesenchymal-like cells</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kalluri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="1417" to="1419" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Tenascin and strictures in inflammatory bowel disease: an immunohistochemical study</title>
		<author>
			<persName><forename type="first">K</forename><surname>Geboes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>El-Zine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Dalle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Surg Pathol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="281" to="286" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Strictures in Crohn&apos;s disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Gelbmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mestermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="210" to="217" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">The role of matrix stiffness in regulating cell behavior</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Wells</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hepatology</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1394" to="1400" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Hinz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Rheumatol Rep</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="120" to="126" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Therapy for fibrotic diseases: nearing the starting line</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sheppard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Duffield</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Transl Med</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="167" to="168" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Infliximab therapy in pulmonary fibrosis associated with collagen vascular disease</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Antoniou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mamoulaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Malagari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Rheumatol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="23" to="28" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Hepatoprotective effect of infliximab, an anti-TNF-alpha agent, on carbon tetrachloride-induced hepatic fibrosis</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Bahcecioglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Koca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">K</forename><surname>Poyrazoglu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Inflammation</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="215" to="221" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Infliximab treatment in a patient with systemic sclerosis associated with lung fibrosis and pulmonary hypertension</title>
		<author>
			<persName><forename type="first">E</forename><surname>Bargagli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Galeazzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bellisai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Respiration</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="346" to="349" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Theiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Simmons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jobin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="36099" to="36109" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Functional modulation of Crohn&apos;s disease myofibroblasts by anti-tumor necrosis factor antibodies</title>
		<author>
			<persName><forename type="first">Di</forename><surname>Sabatino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="137" to="149" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Bacteriology of anal fistulae</title>
		<author>
			<persName><forename type="first">A</forename><surname>De San Ildefonso Pereira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Maruri</forename><surname>Chimeno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Facal</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Esp Enferm Dig</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="533" to="536" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Histological and microbiological assessment of the role of microorganisms in chronic anal fistula</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Lunniss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Faris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Rees</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Surg</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page">1072</biblScope>
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Bacteriology of anal fistulae</title>
		<author>
			<persName><forename type="first">F</forename><surname>Seow-Choen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Hay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Surg</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="27" to="28" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Diversity of the human intestinal microbial flora</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Eckburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Bik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">N</forename><surname>Bernstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">308</biblScope>
			<biblScope unit="page" from="1635" to="1638" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Development of broad-range 16S rDNA PCR for use in the routine diagnostic clinical microbiology service</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Hartley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Microbiol</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="685" to="691" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Assessment of microbiota and peptidoglycan in perianal fistulas</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Van Onkelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Mitalas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Gosselink</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagn Microbiol Infect Dis</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="50" to="54" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Risk factors for perianal Crohn&apos;s disease: the role of genotype, phenotype, and ethnicity</title>
		<author>
			<persName><forename type="first">A</forename><surname>Karban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Itay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Davidovich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="1702" to="1708" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Rivera-Nieves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bamias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vidrich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gastroenterology</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="972" to="982" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Paneth cells as a site of origin for intestinal inflammation</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Adolph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Tomczak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Niederreiter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">503</biblScope>
			<biblScope unit="page" from="272" to="276" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Creation of a caecostoma in mice as a model of an enterocutaneous fistula</title>
		<author>
			<persName><forename type="first">O</forename><surname>Bultmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Philipp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ladeburg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Res Exp Med (Berl)</title>
		<imprint>
			<biblScope unit="volume">198</biblScope>
			<biblScope unit="page" from="215" to="228" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">The mouse arteriovenous fistula model</title>
		<author>
			<persName><forename type="first">B</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Shergill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Fu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Vasc Interv Radiol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="946" to="950" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Altered Tbx1 gene expression is associated with abnormal oesophageal development in the adriamycin mouse model of oesophageal atresia/tracheo-oesophageal fistula</title>
		<author>
			<persName><forename type="first">D</forename><surname>Mc Laughlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Puri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Surg Int</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="143" to="149" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Vascular remodeling and intimal hyperplasia in a novel murine model of arteriovenous fistula failure</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>De Vries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Vasc Surg</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="192" to="201" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">MicroRNAs: new players in IBD</title>
		<author>
			<persName><forename type="first">R</forename><surname>Kalla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">T</forename><surname>Ventham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Kennedy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gut</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="504" to="517" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">MicroRNA signatures differentiate Crohn&apos;s disease from ulcerative colitis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Schaefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Attumi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Opekun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Immunol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">5</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">MicroRNAs classify different disease behavior phenotypes of Crohn&apos;s disease and may have prognostic utility</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Peck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Weiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Inflamm Bowel Dis</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="2178" to="2187" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
